SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-158341
Filing Date
2018-05-10
Accepted
2018-05-10 07:19:48
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d557142d10q.htm 10-Q 323873
2 EX-31.1 d557142dex311.htm EX-31.1 6631
3 EX-31.2 d557142dex312.htm EX-31.2 6618
4 EX-32.1 d557142dex321.htm EX-32.1 3993
5 EX-32.2 d557142dex322.htm EX-32.2 3980
  Complete submission text file 0001193125-18-158341.txt   2678890

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srra-20180331.xml EX-101.INS 415146
7 XBRL TAXONOMY EXTENSION SCHEMA srra-20180331.xsd EX-101.SCH 38085
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20180331_cal.xml EX-101.CAL 49958
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20180331_def.xml EX-101.DEF 118312
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20180331_lab.xml EX-101.LAB 327385
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20180331_pre.xml EX-101.PRE 221789
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 18820482
SIC: 2834 Pharmaceutical Preparations